PARTNERSHIPS We believe collaborating with leading and like-minded partners will create the best-in-class vaccines for patients. 

Evaxion’s business model is geared toward a multi-partner approach focused around single or multiple vaccine target discovery, design and development agreements. Together with our partners, we co-discover and develop vaccines for unmet medical needs, advance drug candidates through clinical testing and realize the full commercial potential of novel scientific discoveries and clinical products.

We firmly believe that strong partnerships enhance our ability to develop effective and impactful vaccines. The combination of our validated and leading AI-Immunology™ platform and in-house vaccine development expertise allows us to accelerate novel vaccine discovery and development together with biotech and pharma companies.